MAP1LC3B and glomerular disorder: Despite these findings, elevation in LC3B expression has been reported in several glomerular diseases [42,43,44], mainly in association with foot process effacement and nephrotic syndrome development, as seen in prorenin receptor conditional knockout mice [45,46].